Hap Trading, LLC Aclaris Therapeutics, Inc. Call Options Transaction History
Hap Trading, LLC
- $935 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.2 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$13.9 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.87 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.75 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $104M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...